Meeting the Challenge of Patient-Centered Clinical Trials
Clinical trials are the proving ground for any new pharmaceutical. On average, these trials take approximately seven and a half years to complete. For manufacturers, who can spend anywhere from $161 million to $2 billion to bring a new drug to market, the returns from investing in this important work have been diminishing. Patient recruitment and retention, which cost $2.3 billion per year, have become a major challenge. Logistics manufacturers are adapting to explosive growth in the use of direct-to-patient clinical trials. Michael Sweeney, director of patient-centric logistics at World Courier Group, discusses the new model’s impact.
For the full article, visit BioPharm International.